MicroRNAs in Breast Cancer Therapy

Author(s): Joy Tang, Aamir Ahmad, Fazlul H. Sarkar

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 33 , 2014

Become EABM
Become Reviewer
Call for Editor


Breast cancer is one of the most common type of cancers as well as a principal cause of cancer-related deaths in women worldwide. Although research has provided a better understanding and diagnosis of breast cancer, studies in breast cancer therapeutics are still far from satisfactory. Recent research on microRNAs (miRNAs) has implicated these tiny regulatory molecules in progression of breast cancer with the possibility of exploiting them as diagnostic and/or prognostic biomarkers. The loss of tumor suppressor miRNAs or overexpression of oncogenic miRNAs can lead to breast cancer tumorigenesis or metastasis. However, the next step – linking miRNAs to cancer therapeutics – is still under progression. The roles of miRNAs exhibit much potential in breast cancer therapy, but currently need to be further studied and evaluated in order to better understand how to apply laboratory results to clinical medicine. Here we provide an update on our current understanding of miRNAs as molecular targets for diagnosis, prognosis and therapy of breast cancers.

Keywords: microRNAs (miRNAs), breast cancer therapy, diagnostic biomarkers, prognostic biomarkers.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [5268 - 5274]
Pages: 7
DOI: 10.2174/1381612820666140128205239
Price: $65

Article Metrics

PDF: 32